Here we investigated for the first time the efficacy of administering human AAT (hAAT) to mitigate salt-induced hypertension in juvenile non-obese 129Sv mice and investigated whether a potential mechanism for this protective effect of hAAT could be due to the suppression of PKC activity as a result of decreased levels of the bioactive lipid DAG. This evidence concerns the gene SERPINA1 and hypertensive disorder.